FFG Venture Business Partners

FFG Venture Business Partners is a corporate venture capital firm founded in 2016 as a wholly owned subsidiary of Fukuoka Financial Group (FFG), one of Japan's leading regional banking groups. Headquartered in Fukuoka, Japan, the firm serves as FFG's dedicated venture investment arm, leveraging the financial group's extensive banking network and institutional resources to support innovative startups across Japan and Asia-Pacific. The team comprises approximately 22 to 29 professionals including six to eight partners. The firm has built a portfolio of over 150 investments, one of the largest CVC portfolios in Japan. Typical check sizes range from $1 million to $5 million, with investments spanning Seed through Series B stages across fintech, AI and deep tech, life sciences, biotech, robotics and IoT, energy, space technology, consumer services, and mobility. Notable portfolio companies include Capsule, Neusignal Therapeutics, ACCELStars, Feliqs, and KaKa Creation. The firm has completed approximately 10 portfolio exits, with the most recent being J-Pharma in March 2026. As a CVC backed by a major regional financial institution, FFG Venture Business Partners brings strategic banking relationships, corporate governance expertise, and access to FFG's extensive corporate client base to its portfolio companies. This is particularly valuable for startups seeking commercial adoption within Japanese enterprises or financial institutions, and for companies planning eventual public listings in Japanese capital markets where FFG's networks provide meaningful structural advantage.